High‐throughput CRISPR‐mediated 3D enrichment platform for functional interrogation of chemotherapeutic resistance-Reference-Cited by-同舟云学术

High‐throughput CRISPR‐mediated 3D enrichment platform for functional interrogation of chemotherapeutic resistance

Published:2021-06-06 Issue:8 Volume:118 Page:3187-3199
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotech & Bioengineering

Author:

Grandhi Taraka S. P.¹^ORCID,To Jeremy,Romero Angelica,Luna Fabio,Barnes Whitney,Walker John,Moran Rita,Newlin Robbin,Miraglia Loren,Orth Anthony P.,Horman Shane R.

Affiliation:

1. Genomics Institute of the Novartis Research Foundation San Diego CA USA

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.27844

Reference39 articles.

1. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

2. Spatial competition constrains resistance to targeted cancer therapy

3. The emerging role of zinc transporters in cellular homeostasis and cancer

4. Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis

5. Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress of 3D Organoid Technology for Preclinical Investigations: Towards Human In Vitro Models;International Journal of Drug Discovery and Pharmacology;2022-12-21

2. A CRISPR Path to Finding Vulnerabilities and Solving Drug Resistance: Targeting the Diverse Cancer Landscape and Its Ecosystem;Advanced Genetics;2022-11-09

3. Research Progress with Luteolin as an Anti-Tumor Agent;Natural Product Communications;2022-11